Total Payments
$232,040
2024 Payments
$13,244
Companies
44
Transactions
2,104
Medicare Patients
6,314
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$160,617 (69.2%)
Food & Beverage$31,833 (13.7%)
Travel$23,597 (10.2%)
Consulting$15,677 (6.8%)
Education$317.04 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $129,830 | 84 | 56.0% |
| Food and Beverage | $31,833 | 1,893 | 13.7% |
| Honoraria | $30,547 | 18 | 13.2% |
| Travel and Lodging | $23,597 | 86 | 10.2% |
| Consulting Fee | $15,677 | 10 | 6.8% |
| Education | $317.04 | 12 | 0.1% |
| Grant | $239.52 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $58,907 | 177 | $0 (2024) |
| Amgen Inc. | $49,289 | 374 | $0 (2024) |
| ABBVIE INC. | $32,508 | 246 | $0 (2024) |
| Horizon Therapeutics plc | $28,727 | 126 | $0 (2023) |
| PFIZER INC. | $17,869 | 224 | $0 (2024) |
| MEDAC PHARMA, INC. | $10,908 | 43 | $0 (2018) |
| MEDEXUS PHARMA, INC. | $9,981 | 20 | $0 (2019) |
| Horizon Pharma plc | $6,546 | 44 | $0 (2018) |
| Cardinal Health 108, LLC | $3,334 | 14 | $0 (2019) |
| Janssen Biotech, Inc. | $2,246 | 103 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,244 | 167 | Amgen Inc. ($10,314) |
| 2023 | $11,349 | 195 | Amgen Inc. ($8,363) |
| 2022 | $26,814 | 226 | Horizon Therapeutics plc ($13,539) |
| 2021 | $21,977 | 242 | Horizon Therapeutics plc ($13,459) |
| 2020 | $14,517 | 245 | Amgen Inc. ($10,513) |
| 2019 | $51,795 | 348 | Celgene Corporation ($25,210) |
| 2018 | $37,498 | 308 | Celgene Corporation ($16,125) |
| 2017 | $54,845 | 373 | Celgene Corporation ($17,558) |
All Payment Transactions
2,104 individual payment records from CMS Open Payments — Page 1 of 85
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/12/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $232.50 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/14/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $89.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,304 | 18,360 | $685,687 | $240,090 |
| 2022 | 17 | 1,388 | 16,942 | $695,974 | $228,964 |
| 2021 | 16 | 1,669 | 19,269 | $758,903 | $254,561 |
| 2020 | 20 | 1,953 | 60,881 | $1.3M | $504,320 |
Total Patients
6,314
Total Services
115,452
Medicare Billing
$1.2M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 60 | 5,580 | $195,300 | $103,230 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 464 | $125,280 | $43,596 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 371 | 594 | $109,296 | $39,402 | 36.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 86 | 244 | $57,551 | $18,990 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $39,425 | $11,920 | 30.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 45 | 168 | $45,360 | $7,582 | 16.7% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2023 | 17 | 10,416 | $31,248 | $5,042 | 16.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 114 | 300 | $19,200 | $3,226 | 16.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 44 | 60 | $10,500 | $2,952 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,914 | $1,568 | 31.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 18 | $3,613 | $1,120 | 31.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 26 | 130 | $39,000 | $842.62 | 2.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 27 | 35 | $1,400 | $307.32 | 22.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 111 | 181 | $2,715 | $152.55 | 5.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 18 | 24 | $720.00 | $146.25 | 20.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 33 | $165.00 | $14.46 | 8.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 47 | 4,620 | $162,600 | $79,565 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 458 | 730 | $134,305 | $47,370 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 456 | $123,120 | $41,582 | 33.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 73 | 200 | $47,299 | $15,708 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 100 | 100 | $41,500 | $12,722 | 30.7% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2022 | 12 | 9,744 | $29,232 | $12,482 | 42.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 45 | 143 | $38,610 | $7,135 | 18.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 60 | 73 | $14,819 | $4,002 | 27.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 126 | 363 | $42,717 | $3,807 | 8.9% |
About Dr. Rajesh Kataria, DO
Dr. Rajesh Kataria, DO is a Rheumatology healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619072188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajesh Kataria, DO has received a total of $232,040 in payments from pharmaceutical and medical device companies, with $13,244 received in 2024. These payments were reported across 2,104 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($129,830).
As a Medicare-enrolled provider, Kataria has provided services to 6,314 Medicare beneficiaries, totaling 115,452 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Wheelersburg, OH
- Active Since 09/13/2006
- Last Updated 11/23/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619072188
Products in Payments
- Otezla (Drug) $101,119
- Rasuvo (Drug) $20,890
- PENNSAID (Drug) $16,814
- LYRICA (Drug) $16,097
- Humira (Biological) $11,263
- RAYOS (Drug) $6,766
- KRYSTEXXA (Drug) $6,452
- KRYSTEXXA (Biological) $2,743
- Enbrel (Biological) $2,664
- DUEXIS (Drug) $2,520
- Otezla (Biological) $2,038
- RINVOQ (Biological) $2,034
- Cimzia (Drug) $1,905
- TREMFYA (Drug) $1,472
- ORENCIA (Biological) $1,386
- COSENTYX (Biological) $1,376
- XELJANZ (Drug) $1,115
- EVENITY (Biological) $852.27
- TALTZ (Drug) $826.95
- BENLYSTA (Biological) $817.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.